These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 14527238)

  • 101. The prevalence of physicians who emphasize wellness and provide educational materials for their patients.
    Cardarelli R; Licciardone JC; Spies L
    J Health Care Poor Underserved; 2003 May; 14(2):175-81. PubMed ID: 12739298
    [No Abstract]   [Full Text] [Related]  

  • 102. Prescription tracking and public health.
    Fugh-Berman A
    J Gen Intern Med; 2008 Aug; 23(8):1277-80. PubMed ID: 18473146
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Should Canada allow direct-to-consumer advertising of prescription drugs?: yes.
    Wong-Rieger D
    Can Fam Physician; 2009 Feb; 55(2):130, 132, 134 passim. PubMed ID: 19221066
    [No Abstract]   [Full Text] [Related]  

  • 104. Adherence of Drug Promotional Literatures Distributed by Pharmaceutical Companies to World Health Organization Ethical Criteria for Medicinal Drug Promotion.
    Prasad P; Bajracharya SR; Deo S; Lamichhane S; Pradhan PMS; Ghimire R; Pokharel A
    J Nepal Health Res Counc; 2019 Nov; 17(3):345-350. PubMed ID: 31735930
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Prescription drug samples: making decisions with imperfect data.
    Whittle J; Good CB
    J Gen Intern Med; 2008 Jun; 23(6):890-2. PubMed ID: 18461406
    [No Abstract]   [Full Text] [Related]  

  • 106. European practice in haemodialysis: results of the EPD.
    De Vos JY; Elseviers M; Harrington M; Zampieron A; Vlaminck H; Ormandy P; Kafkia T;
    EDTNA ERCA J; 2006; 32(1):20-3. PubMed ID: 16700163
    [TBL] [Abstract][Full Text] [Related]  

  • 107. A National Survey of the Frequency of Drug Company Detailing Visits and Free Sample Closets in Practices Delivering Primary Care.
    King AC; Schwartz LM; Woloshin S
    JAMA Intern Med; 2020 Apr; 180(4):592-595. PubMed ID: 31985742
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Drug samples in dermatology: out of the closet, into the dustbin.
    Katz KA; Reid EE; Chren MM
    JAMA Dermatol; 2014 May; 150(5):483-5. PubMed ID: 24740350
    [No Abstract]   [Full Text] [Related]  

  • 109. Pharmaceutical penetration of new drug and pharmaceutical market structure in Taiwan: hospital-level prescription of thiazolidinediones for diabetes.
    Tsai YW; Wen YW; Huang WF; Kuo KN; Chen PF; Shih HW; Lee YC
    Eur J Health Econ; 2010 Jun; 11(3):279-90. PubMed ID: 19649666
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Impact of e-detailing on the number of new prescriptions.
    Gönül FF; Carter FJ
    Health Care Manag Sci; 2010 Jun; 13(2):101-11. PubMed ID: 20629413
    [TBL] [Abstract][Full Text] [Related]  

  • 111. The good, the bad, and the ugly of free drug samples.
    Poligone B
    JAMA Dermatol; 2014 Nov; 150(11):1237-8. PubMed ID: 25188835
    [No Abstract]   [Full Text] [Related]  

  • 112. Understanding the effects of pharmaceutical promotion: a neural network approach guided by genetic algorithm-partial least squares.
    Lim CW; Kirikoshi T
    Health Care Manag Sci; 2008 Dec; 11(4):359-72. PubMed ID: 18998595
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Capturing prescribers' minds.
    Drug Ther Bull; 2000 Jul; 38(7):55-6. PubMed ID: 11027116
    [TBL] [Abstract][Full Text] [Related]  

  • 114. An information infrastructure for the pharmaceutical market.
    Reinhardt UE
    Health Aff (Millwood); 2004; 23(1):107-12. PubMed ID: 15002633
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Are we too fixated on clinical trial data? The case for using embedded case histories to influence prescribing.
    Black I
    Health Mark Q; 2005; 23(1):3-19. PubMed ID: 16891254
    [TBL] [Abstract][Full Text] [Related]  

  • 116. [Drug combinations in the care of bed sores].
    Marinho Ade M
    Rev Bras Enferm; 1997; 50(2):257-74. PubMed ID: 9775937
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Key opinion leaders - a critical perspective.
    Scher JU; Schett G
    Nat Rev Rheumatol; 2021 Feb; 17(2):119-124. PubMed ID: 33257869
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Patterns of Pharmaceutical Industry Marketing to Physicians for Direct-Acting Antivirals, 2013 Through 2019.
    Jiang S; Anderson TS; Marcum ZA
    Ann Pharmacother; 2022 Feb; 56(2):229-231. PubMed ID: 34142562
    [No Abstract]   [Full Text] [Related]  

  • 119. Sample medications and the uninsured.
    Hubbard MJ
    J Am Board Fam Pract; 2003; 16(1):87. PubMed ID: 12583660
    [No Abstract]   [Full Text] [Related]  

  • 120. Physiotherapists' use of medications and the influence of drug companies.
    Sullivan G; Lansbury GF
    Med J Aust; 2001 Feb; 174(4):200. PubMed ID: 11270765
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.